The Interplay of Global Standards and EU Pharmaceutical Regulation: The International Council for Harmonisation (eBook)

Book of the Month

Housing Law Handbook

Diane Astin

Price: £85.00

Buy

More Information

Offers for Newly Called Barristers & Students

Special Discounts for Newly Called & Students

Secondhand & Out of Print

Browse Secondhand Online

The Interplay of Global Standards and EU Pharmaceutical Regulation: The International Council for Harmonisation (eBook)

Sabrina Röttger-Wirtz

ISBN13: 9781509943005

Published: September 2021

Publisher: Hart Publishing

Country of Publication: UK

Format: eBook (ePub)

Price: Out of print
The amount of VAT charged may change depending on your location of use.

The eBooks we sell are sold as a single-user licence and are intended for the end user only.
The sale of some eBooks are restricted to certain countries. To alert you to such restrictions, please select the country of the billing address of your credit or debit card you wish to use for payment.

For further information see https://www.wildy.com/ebook-formats

Once the order is confirmed an e-mail will be sent to you to allow you to download the eBook. For UK purchases this will be automatic. For purchases outside the UK a member of staff will need to confirm the sale. (Staff are available to do this during normal business hours, Mon-Fri 8:30-17:00 UK time)

All eBooks are supplied firm sale and cannot be returned. If you believe there is a fault with your eBook then contact us on ebooks@wildy.com and we will help in resolving the issue. This does not affect your statutory rights.

This eBook is available in the following formats: ePub.

Due to a technical issue some ebooks are not available to order.

Need help with ebook formats?

Also available as

Hardback
9781509942992

£95.00

This book analyses the implementation of global pharmaceutical impact standards in the European risk regulation framework for pharmaceuticals and questions its legitimacy.

Global standards increasingly shape the risk regulation law and policy in the European Union and the area of pharmaceuticals is no exception to this tendency. As this book shows, global pharmaceutical standards set by the International Council for Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH), after they are adopted through the European Medicines Agency (EMA), are an important feature of the regulatory framework for pharmaceuticals in the EU.

In addition to analysing the influence of these global standards in the EU legal and policy framework, the book questions the legitimacy of the Union's reliance on global standards in terms of core administrative law principles of participation, transparency and independence of expertise. It also critically examines the accountability of the European Commission and the European Medicines Agency as participants in the global standard-setting and main implementation gateway of the global pharmaceutical standards into the European Union.

Subjects:: eBooks, Medical Law and Bioethics

Contents:: Introduction; I. EU Pharmaceutical Regulation in a Globalised Market; II. Global Standards: Questions of Legitimacy; III. The Contribution of this Book: The Influence of Global Standards through the EU Lens; IV. The Structure of this Book; PART I; 1. Regulating Pharmaceuticals in the European Union: Law and Administrative Rule-Making; I. EU Pharmaceutical Regulation: Past and Present; II. The Core of the Regulatory Framework: The Marketing Authorisation Procedures; III. The Role of Administrative Rule-Making in EU Pharmaceutical Regulation; IV. Conclusion: Incremental Integration, Extensive (Risk) Regulation and the Significance of Administrative Guidance; 2. EU Risk Regulation in a Globalised World: Global Standards; I. The Phenomenon of Global Standard-Setting; II. The Institutional Landscape of Global Standard-Setting; III. The Interplay between Global Standards and EU Risk Regulation; IV. Conclusion: Institutional Diversity in the Face of Regulatory Complexity; 3. The International Council for Harmonisation: Pharmaceutical Standard-Setting on the Global Level; I. Pharmaceutical Regulation in a Globalised World: The History of the ICH; II. The ICH: Mandate and Membership; III. The ICH: Institutional Structure; IV. The Standard-Setting Process; V. Conclusion: The Reformed ICH in Perspective; 4. The Implementation of ICH Standards in the European Union; I. A Closer Look at the ICH Guidelines; II. Implementing Global Standards in the EU: The Integration of ICH Standards in EU Pharmaceutical Law; III. The Influence of ICH Guidelines on Legislation, Commission Guidelines and the Court of Justice; IV. Conclusion: ICH Guidelines as Integral Parts of the EU Regulatory Framework for Pharmaceuticals; PART II; 5. Questioning the Legitimacy of Global Standards; I. Why Should the Legitimacy of Global Standards Be Examined?; II. What Constitutes Legitimacy on the Global Level?; III. Administrative Law and Global Standards; IV. Applying the Perspective of European Administrative Law; V. Conclusion: In Search of Legitimacy; 6. Examining the Legitimacy of the ICH Standard-Setting Procedure and Uploading EU Administrative Law; I. The Principle of Participation; II. The Principle of Independent Expertise; III. The Principle of Transparency; IV. Discussing Remedies: The Introduction of Ex-ante and Ex-post Procedures in the Process of Implementation; V. Conclusion: Undermining and Uploading Procedural Standards; 7. Global Pharmaceutical Standards as a Challenge for EU Law: Remedies within the EU; I. Political Accountability within the EU for Global Pharmaceutical Standards: A Remedy with Limits; II. Legal Accountability: Judicial Review of ICH Guidelines within the EU; III. A Broader Perspective: Global Standards as a Challenge for European Law – The Potential for Juridification; IV. Conclusion: Accountability Gaps and Juridification; Conclusion; I. Pharmaceutical Regulation in a Globalised World; II. The Legitimacy of Global Pharmaceutical Standards; III. Lessons Learned from 'Uploading' EU Law to the ICH; IV. The Implementation of Global Standards as a Legitimacy Challenge for the EU